Tag Archives: Jason Mccarthy
Analysts Are Bullish on These Healthcare Stocks: Karuna Therapeutics (KRTX), Sensus Healthcare (SRTS)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Karuna Therapeutics (KRTX – Research Report) and Sensus Healthcare (SRTS – Research Report) with bullish sentiments. Karuna Therapeutics (KRTX) In a report
Maxim Group Reaffirms Their Buy Rating on Inmune Bio (INMB)
Maxim Group analyst Jason McCarthy maintained a Buy rating on Inmune Bio (INMB – Research Report) on March 26 and set a price target of $13.00. The company’s shares closed last Monday at $20.80. According to TipRanks.com, McCarthy is a
Maxim Group Keeps a Buy Rating on Heat Biologics (HTBX)
In a report issued on March 26, Jason McCarthy from Maxim Group maintained a Buy rating on Heat Biologics (HTBX – Research Report), with a price target of $14.00. The company’s shares closed last Monday at $8.37. According to TipRanks.com,
AIM ImmunoTech (AIM) Receives a Buy from Maxim Group
Maxim Group analyst Jason McCarthy maintained a Buy rating on AIM ImmunoTech (AIM – Research Report) on March 26 and set a price target of $2.00. The company’s shares closed last Monday at $2.58. According to TipRanks.com, McCarthy is a
Analysts Are Bullish on Top Healthcare Stocks: Antibe Therapeutics (ATBPF), Agenus (AGEN)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Antibe Therapeutics (ATBPF – Research Report) and Agenus (AGEN – Research Report) with bullish sentiments. Antibe Therapeutics (ATBPF) In a report issued
Maxim Group Issues a Buy Rating on Matinas BioPharma (MTNB)
In a report released yesterday, Jason McCarthy from Maxim Group assigned a Buy rating to Matinas BioPharma (MTNB – Research Report), with a price target of $3.00. The company’s shares closed last Friday at $1.46. According to TipRanks.com, McCarthy is
